+Search query
-Structure paper
Title | Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2. |
---|---|
Journal, issue, pages | Nat Commun, Vol. 12, Page 3802-3802, Year 2021 |
Publish date | Dec 7, 2020 (structure data deposition date) |
Authors | Higuchi, Y. / Suzuki, T. / Arimori, T. / Ikemura, N. / Mihara, E. / Kirita, Y. / Ohgitani, E. / Mazda, O. / Motooka, D. / Nakamura, S. ...Higuchi, Y. / Suzuki, T. / Arimori, T. / Ikemura, N. / Mihara, E. / Kirita, Y. / Ohgitani, E. / Mazda, O. / Motooka, D. / Nakamura, S. / Sakai, Y. / Itoh, Y. / Sugihara, F. / Matsuura, Y. / Matoba, S. / Okamoto, T. / Takagi, J. / Hoshino, A. |
External links | Nat Commun / PubMed:34155214 |
Methods | X-ray diffraction |
Resolution | 3.2 Å |
Structure data | PDB-7dmu: |
Chemicals | ChemComp-NAG: ChemComp-ZN: ChemComp-SO4: ChemComp-HOH: |
Source |
|
Keywords | VIRAL PROTEIN / SARS-CoV-2 / COVID-19 / ACE2 |